Eiján AM - Search Results

1

Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.

Alvarez V, Lodillinsky C, Umerez S, Sandes E, Eiján AM. Alvarez V, et al. Among authors: eijan am. Int J Mol Med. 2005 Oct;16(4):565-71. Int J Mol Med. 2005. PMID: 16142388

2

Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability.

Guerra FK, Eijan AM, Puricelli L, Alonso DF, Bal de Kier Joffé E, Kornblihgtt AR, Charreau EH, Elizalde PV. Guerra FK, et al. Among authors: eijan am. Int J Cancer. 1996 Mar 15;65(6):812-20. doi: 10.1002/(SICI)1097-0215(19960315)65:6<812::AID-IJC18>3.0.CO;2-5. Int J Cancer. 1996. PMID: 8631597

3

Influence of mast cells on two murine mammary adenocarcinomas.

de Cidre LL, Eijan AM, Bertolesi G, Isturiz M, Sacerdote de Lustig E. de Cidre LL, et al. Among authors: eijan am. Tumour Biol. 1996;17(6):345-53. doi: 10.1159/000217999. Tumour Biol. 1996. PMID: 8938950

4

Differential nitric oxide release and sensitivity to injury in different murine mammary tumor cell lines.

Eijan AM, Davel LE, Rueda HA, Rozenberg G, De Lustig ES, Jasnis MA. Eijan AM, et al. Int J Mol Med. 1998 Nov;2(5):625-30. doi: 10.3892/ijmm.2.5.625. Int J Mol Med. 1998. PMID: 9858663

5

A synthetic, nitrogenated antimetastatic and anti-angiogenic compound with low toxicity in vivo.

Cerutti ML, D'Orio E, Davel L, Colombo L, Parma P, Diament M, Stillitani I, Gelpi ME, Leicach SR, Eiján AM. Cerutti ML, et al. Among authors: eijan am. Int J Oncol. 1999 Mar;14(3):585-91. doi: 10.3892/ijo.14.3.585. Int J Oncol. 1999. PMID: 10024695

6

Cathepsin B levels in urine from bladder cancer patients.

Eiján AM, Sandes E, Puricelli L, Bal De Kier Joffé E, Casabé AR. Eiján AM, et al. Oncol Rep. 2000 Nov-Dec;7(6):1395-9. doi: 10.3892/or.7.6.1395. Oncol Rep. 2000. PMID: 11032951

7

Characterization of a fibroblastoid mammary carcinoma cell line (LM2) originated from a mouse adenocarcinoma.

Galli S, Colombo L, Vanzuli S, Daroqui MC, del Carmen Vidal M, Jasnis MA, Sacerdote de Lustig E, Eijan AM. Galli S, et al. Among authors: eijan am. Int J Oncol. 2000 Dec;17(6):1259-65. doi: 10.3892/ijo.17.6.1259. Int J Oncol. 2000. PMID: 11078814

8

Reactivity of tumor-draining lymph nodes and the nitric oxide pathway.

Davel L, Eijan AM, Sales ME, Español A, D'Agostino A, Piccardo I, Lauría L, De Lustig ES, Jasnis MA. Davel L, et al. Among authors: eijan am. Int J Oncol. 2002 Jan;20(1):59-67. Int J Oncol. 2002. PMID: 11743643

9

Nitric oxide synthase, arginase and cyclooxygenase are involved in muscarinic receptor activation in different murine mammary adenocarcinoma cell lines.

Español A, Eiján AM, Mazzoni E, Davel L, Jasnis MA, Sacerdote De Lustig E, Sales ME. Español A, et al. Among authors: eijan am. Int J Mol Med. 2002 Jun;9(6):651-7. Int J Mol Med. 2002. PMID: 12011984

10

Nitric oxide in patients with transitional bladder cancer.

Eiján AM, Piccardo I, Riveros MD, Sandes EO, Porcella H, Jasnis MA, Sacerdote De Lustig E, Malagrino H, Pasik L, Casabé AR. Eiján AM, et al. J Surg Oncol. 2002 Dec;81(4):203-8. doi: 10.1002/jso.10170. J Surg Oncol. 2002. PMID: 12451625

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters